Search Results

March 21, 2013 | National Law Journal

Damages Stipulation Cannot Be Used to Avoid U.S. Courts, Justices Say

WASHINGTON - Plaintiffs lawyers in proposed class actions cannot avoid federal courts by promising to seek less than $5 million in damages, according to a unanimous U.S. Supreme Court.

1 minute read

TABONE, SAMUEL L. v LEE, M.D., KEUN Y.

Publication Date: 2009-02-06
Practice Area:
Industry:
Court: Appellate Division, 4th Dept
Judge:
Attorneys: For plaintiff:
for defendant:
Case Number: 1415

SUPREME COURT OF THE STATE OF NEW YORK Appellate Division, Fourth Judicial Department 1415 CA 08-01085 PRESENT: HURLBUTT, J.P., MARTOCHE,

Clayworth v. Pfizer, Inc.

Publication Date: 2010-07-12
Practice Area:
Industry:
Date Filed: 2010-07-12
Court: Ca. Sup. Ct.
Judge:
Attorneys: For plaintiff: Attorneys for Appellant: Alioto Law Firm, Joseph M. Alioto, Joseph M. Alioto, Jr., Theresa D. Moore, Angelina Alioto-Grace, Thomas P. Pier; Law Offices of John H. Boone, John H. Boone; Foreman & Brasso, Russell F. Brasso; Law Offices of James M. Dombroski, James M. Dombroski; Law Offices of Jeffery K. Perkins, Jeffrey K. Perkins; Gary D. McCallister & Associates, Gary D. McCallister, Thomas A. Kelliher, Eric I. Unrein and Jaime Goldstein for Plaintiffs and Appellants. Coughlin Stoia Geller Rudman & Robbins, Pamela M. Parker; Schubert Jonckheer Kolbe & Kralowec and Kimberly A. Kralowec for Consumer Attorneys of California as Amicus Curiae on behalf of Plaintiffs and Appellants. Zelle Hofmann Voelbel & Mason, Craig C. Corbitt and Henry A. Cirillo for Pharmacists Planning Services, Inc., as Amicus Curiae on behalf of Plaintiffs and Appellants.
for defendant: Attorneys for Respondent: Filice Brown Eassa & McLeod, Peter A. Strotz, Paul R. Johnson, William E. Steimle; Davis Polk & Wardwell, Ameila Starr, Arthur F. Golden, William J. Fenrich and Daniel J. Schwartz for Defendant and Respondent AstraZeneca LP. Winston & Strawn, Tyler M. Paetkau, Nicole P. Dogwill, James F. Hurst, Susan A. Pipal, Matthew J. Sullivan; Eimer Stahl Klevorn & Solberg, David M. Stahl, J. Cunyon Gordon and Adam Oyenbanji for Defendant and Respondent Abbott Laboratories. Gibson, Dunn & Crutcher, Jeffrey T. Thomas and James N. Knight for Defendant and Respondent Allergan, Inc. Mayer, Brown, Rowe & Maw, Mayer Brown, Donald M. Falk, John Nadolenco, Mack Anderson; Sheppard Mullin Richter & Hampton, Steven O. Kramer, John P. Stigi III; Hogan & Hartson and Joseph H. Young for Defendant and Respondent Amgen, Inc. Covington & Burling, Elizabeth Abigail Brown, Anita F. Stork, Theodore Voorhees, Jr., and Thomas J. Cosgrove for Defendant and Respondent Boehringer Ingelheim Pharmaceuticals, Inc. Sedgwick, Detert, Moran & Arnold, Paul J. Riehle, Matthew A. Fischer; Cravath, Swaine & Moore, Evan R. Chesler, Elizabeth L. Grayer, Jessica Buturla and Jeffrey B. Korn for Defendant and Respondent Bristol-Myers Squibb Company. Reed Smith, Michael Diane Floyd, Kirsten J. Handelman; Oppenheimer Wolff & Donnelly, Gary Hansen, David Graham and Aaron Mills Scott for Defendant and Respondent Eli Lilly & Company. Irell & Manella, Alexander F. Wiles, John C. Keith; Cleary Gottlieb Steen & Hamilton, George S. Cary, Sara D. Schotland and David I. Gelfand for Defendant and Respondent GlaxoSmithKline PLC. Drinker Biddle & Reath, H. Christian L?Orange, Paul H. Saint-Antoine, Mary E. Kohart, David J. Antczak and Joanne C. Lewers for Defendant and Respondent Hoffmann-La Roche Inc. Folger Levin & Kahn, Crowell & Moring, Beatrice Bich-Dao Nguyen, Samuel Ray Miller, Tracy E. Reichmuth, Cecilia C. Ogbu, Steven E. Wilson; Patterson Belknap Webb & Tyler, William Cavanaugh, Jr., and Cecilia B. Loving for Defendants and Respondents Janssen Pharmaceutica Inc., Johnson & Johnson Health Care Systems, Inc., Ortho Biotech, Inc., and Ortho-McNeil Pharmaceutical, Inc. Hughes Hubbard & Reed, Rita M. Haeusler, John M. Townsend, Scott H. Christensen, James A. Graffam; Orrick, Herrington & Sutcliffe, Robert P. Reznick and David Goldstein for Defendant and Respondent Merck Sharp & Dohme Corp. formerly known as Merck & Co., Inc. Kaye Scholer, Aton Arbisser, Bryant S. Delgadillo, Saul P. Morgenstern, Karin E. Garvey; Faegre & Benson, James A. O?Neal and Kim J. Walker for Defendant and Respondent Novartis Pharmaceuticals Corporation. Nossaman, Gunther, Knox & Elliott, Nossaman, Scott DeVries, Katrina June Lee; Dickstein Shapiro, Peter J. Kadzik, Bernard Nash, Maria Colsey Heard, Milton Marquis and Andres Colin for Defendant and Respondent Pfizer Inc. Latham & Watkins, Charles H. Samel, Jennifer A. Carmassi, Margaret M. Zwisler, Steven H. Schulman and Belinda S. Lee for Defendant and Respondent Pharmaceutical Research and Manufacturers of America. Arnold & Porter, Ronald C. Redcay, Douglas L. Wald, Mark R. Merley, Daniel R. Waldman, Anne P. Davis and Ryan Z. Watts for Defendant and Respondent Wyeth.
Case Number: No. S166435

Cite as 10 C.D.O.S. 87895JAMES CLAYWORTH et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Def

October 1, 2012 | National Law Journal

A term under construction

With its blockbuster health care, immigration and other high-profile decisions, the U.S. me Court's last term would seem hard to rival, but the new term may do just that. "The

1 minute read

October 10, 2012 | The Legal Intelligencer

Law Surrounding Third-Party Liability of Law Firms in Spotlight

When a company collapses and creditors or a trustee are looking to recoup losses, banks and accounting firms have often been targeted under the theory that it was their advice or their ignora

1 minute read

October 12, 2012 | The American Lawyer

The Churn: Lateral Moves and Promotions in the Am Law 200

Akin Gump Strauss Hauer & Feld raided Haynes and Boone's Dallas office this week, picking up a seven-partner group of corporate and litigation attorneys for its own Dallas operatio

1 minute read

November 6, 2012 | New York Law Journal

Automated Trading Errors Give Rise to New Compliance Concerns

Computers are playing an ever greater role at companies that trade equities, commodities and derivatives, notably in relation to order management. Many trading firms apply automated strategie

1 minute read

June 25, 2009 | New Jersey Law Journal

Unpublished Opinions

STATE COURT CASES ADMINISTRATIVE LAW AND PROCEDURE — DUE PROCESS — LICENSES 01-2-4219 Dept. of Health and Senior Services v. Charles , App. Div. (per

1 minute read

December 1, 2012 | Corporate Counsel

No Slacking Off

With its blockbuster health care, immigration and other high-profile decisions, the U.S. Supreme Court's last term would seem hard to rival. But the new term may do just

1 minute read

August 29, 2012 | New York Law Journal

Marketplace

San Francisco-based Salesforce.com will be increasing its presence in Manhattan, signing a 10-year lease for 74,349 square feet at 685 Third Ave. The high-tech company will have the entire si

1 minute read